Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)

Condition:   Exudative Age-Related Macular DegenerationIntervention:   Sponsors:   The Retina Center of St. Louis County, PC;   ZeaVision, Inc.Recruiting - verified November 2014

Source: ClinicalTrials.gov - January 27, 2012 Category: Research Source Type: clinical trials